These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3610218)

  • 1. The mode of action of methotrexate-monoclonal antibody conjugates.
    Smyth MJ; Pietersz GA; McKenzie IF
    Immunol Cell Biol; 1987 Apr; 65 ( Pt 2)():189-200. PubMed ID: 3610218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates.
    Kanellos J; Pietersz GA; Cunningham Z; McKenzie IF
    Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():483-93. PubMed ID: 3502340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary.
    Pietersz GA; Cunningham Z; McKenzie IF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular uptake and cytotoxicity of chlorambucil-monoclonal antibody conjugates.
    Smyth MJ; Pietersz GA; McKenzie IF
    Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():315-21. PubMed ID: 3679288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.
    Uadia P; Blair AH; Ghose T; Ferrone S
    J Natl Cancer Inst; 1985 Jan; 74(1):29-35. PubMed ID: 3855485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
    Shen WC; Ballou B; Ryser HJ; Hakala TR
    Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
    Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
    Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.
    Kanellos J; Pietersz GA; McKenzie IF
    J Natl Cancer Inst; 1985 Aug; 75(2):319-32. PubMed ID: 2991647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumour therapy of solid tumours with ricin-antibody conjugates.
    Kanellos J; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():89-99. PubMed ID: 2786496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies of whole ricin monoclonal antibody immunoconjugates for the treatment of murine tumours.
    Kanellos J; MacKenzie IF; Pietersz GA
    Immunol Cell Biol; 1988; 66 ( Pt 5-6)():403-15. PubMed ID: 3265693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of an MTX-HSA-MoAb conjugate.
    Fitzpatrick JJ; Garnett MC
    Anticancer Drug Des; 1995 Jan; 10(1):11-24. PubMed ID: 7695811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(L-lysine) has different membrane transport and drug-carrier properties when complexed with heparin.
    Shen WC; Ryser HJ
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7589-93. PubMed ID: 6950400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA; Smyth MJ; McKenzie IF
    Cancer Res; 1988 Feb; 48(4):926-31. PubMed ID: 3422182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monensin is obligatory for the cytotoxic action of a disulfide linked methotrexate-anti-transferrin receptor conjugate.
    Raso V; Fehrmann C; Solan VC; Rosowsky A
    Biochem Biophys Res Commun; 1988 Jan; 150(1):104-10. PubMed ID: 3276306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.
    Rowland AJ; Harper ME; Wilson DW; Griffiths K
    Br J Cancer; 1990 May; 61(5):702-8. PubMed ID: 2337507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
    Smyth MJ; Foster HM; Andrew SM; Teh JG; Krauer K; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():167-79. PubMed ID: 8349300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites.
    Uadia PO; Blair AH; Ghose T
    Cancer Chemother Pharmacol; 1988; 22(2):175-7. PubMed ID: 3409449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.